"s1" Pill Images
The following drug pill images match your search criteria.
![Pill SL 342 White Oval is Sulfamethoxazole and trimethoprim DS](https://www.drugs.com/images/pills/mmx/t104915f/sulfamethoxazole-and-trimethoprim-ds.jpg)
SL 342
Sulfamethoxazole and trimethoprim DS
- Strength
- 800 mg / 160 mg
- Imprint
- SL 342
- Color
- White
- Shape
- Oval
![Pill 5697 DAN PRAZOSIN Yellow is Prazosin Hydrochloride](/img/pillid/no-image-placeholder.png)
5697 DAN PRAZOSIN
![Pill MYLAN 5150 MYLAN 5150 Purple Capsule/Oblong is Nizatidine](https://www.drugs.com/images/pills/nlm/003785150.jpg)
1 / 5
Loading
MYLAN 5150 MYLAN 5150
1 / 3
Loading
ESL 200
![Pill WPI 2510 White Round is Budesonide Extended-Release](https://www.drugs.com/images/pills/custom/pill27632-1/budesonide-extended-release.jpeg)
WPI 2510
![Pill USL 80 USL 80 Purple Capsule/Oblong is Zinc Sulfate](https://www.drugs.com/images/pills/mmx/t100051f/zinc-sulfate.jpg)
1 / 2
Loading
USL 80 USL 80
![Pill P251 White Capsule/Oblong is Hyoscyamine Sulfate Extended Release](https://www.drugs.com/images/pills/nlm/200000936.jpg)
P251
Hyoscyamine Sulfate Extended Release
- Strength
- 0.375 mg
- Imprint
- P251
- Color
- White
- Shape
- Capsule/Oblong
![Pill LU F51 White Round is Fyavolv](/img/pillid/no-image-placeholder.png)
LU F51
Fyavolv
- Strength
- ethinyl estradiol 0.0025 mg / norethindrone acetate 0.5 mg
- Imprint
- LU F51
- Color
- White
- Shape
- Round
![Pill 551 Blue Capsule/Oblong is Minocycline Hydrochloride Extended-Release](/img/pillid/no-image-placeholder.png)
551
Minocycline Hydrochloride Extended-Release
- Strength
- 80 mg
- Imprint
- 551
- Color
- Blue
- Shape
- Capsule/Oblong
![Pill 3M NORGESIC White & Yellow Round is Norgesic](https://www.drugs.com/images/pills/mmx/t105236f/norgesic.jpg)
1 / 2
Loading
3M NORGESIC
Norgesic
- Strength
- 385 mg / 30 mg / 25 mg
- Imprint
- 3M NORGESIC
- Color
- White & Yellow
- Shape
- Round
![Pill SL 469 Green Round is Propranolol Hydrochloride](https://www.drugs.com/images/pills/mtm/Propranolol%2040%20mg-SID.jpg)
1 / 4
Loading
SL 469
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.